March 4, 2015 | InsuLine Medical CEO Mike Netz resigned from his position after the company’s share price dropped seventy percent. The big dip the company’s share price occurred after the company announced that it was unable to secure the proper insurance clearance for its product for the treatment of diabetes in Germany. The company reports that Netz will be temporarily replaced by Eyal Levy, a member of the company’s board. Insuline Medical was founded in 2007 and is headquartered in Petah Tikvah.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
New Program Supporting Early-Stage Construction Startups In North
October 13, 2024
IAI Launches First US Innovation Center, New Accelerator Program
October 13, 2024
Israeli Cybersecurity Startup To Provide Training For IDF
October 10, 2024
Johnson & Johnson Completes Purchase Of Israeli Startup V-Wave
October 10, 2024
Facebook comments